Novavax, Inc. (NASDAQ:NVAX – Get Free Report) saw strong trading volume on Monday . 9,311,906 shares were traded during trading, an increase of 46% from the previous session’s volume of 6,399,364 shares.The stock last traded at $8.29 and had previously closed at $7.14. Analyst Ratings Changes Several analysts have recently issued reports on the stock. […]
StockNews.com assumed coverage on shares of Novavax (NASDAQ:NVAX – Free Report) in a report released on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. B. Riley upgraded Novavax from a neutral rating to a buy rating […]
Moderna Inc. said Thursday that preliminary clinical trial data show that its updated COVID-19 vaccine is effective against newer variants that are starting.
Pfizer, Moderna, and Novavax are getting ready to roll out updated Covid-19 vaccines that will target recent strains, though not specifically the most.
HC Wainwright reissued their buy rating on shares of Novavax (NASDAQ:NVAX – Free Report) in a research note published on Thursday morning, Benzinga reports. They currently have a $35.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also recently commented on NVAX. B. Riley upgraded Novavax from a neutral rating to a […]